|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-12-12
|
|
pubmed:abstractText |
Because different tumor necrosis factor alpha (TNFalpha) blockers may have distinct immunomodulatory effects on specific disease manifestations, the present study was carried out to investigate the immunomodulating effects of etanercept on peripheral synovitis in the spondylarthropathies (SpA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3898-909
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16329106-Adult,
pubmed-meshheading:16329106-Aged,
pubmed-meshheading:16329106-Antirheumatic Agents,
pubmed-meshheading:16329106-Bone and Bones,
pubmed-meshheading:16329106-Cartilage,
pubmed-meshheading:16329106-Down-Regulation,
pubmed-meshheading:16329106-Extracellular Matrix,
pubmed-meshheading:16329106-Female,
pubmed-meshheading:16329106-Humans,
pubmed-meshheading:16329106-Immunoglobulin G,
pubmed-meshheading:16329106-Immunologic Factors,
pubmed-meshheading:16329106-Knee Joint,
pubmed-meshheading:16329106-Male,
pubmed-meshheading:16329106-Middle Aged,
pubmed-meshheading:16329106-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:16329106-Spondylarthropathies,
pubmed-meshheading:16329106-Synovial Membrane,
pubmed-meshheading:16329106-Synovitis,
pubmed-meshheading:16329106-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies.
|
|
pubmed:affiliation |
Ghent University Hospital, Ghent, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
